As of 05 Nov 2026 22:43 UTC. Status is always as stated in the latest recorded notice; the sources do not publish resolution, so nothing on this page says a medicine is back — see methodology.
Presentations, as stated in the latest recorded notice
Each line is re-expressed from MSN/2023/073 (31 Jul 2023): the product named, the status the source stated, and the expected-back phrase kept as written. Not the source's sentence, and not an observation of stock.
| Presentation | Status, as stated | Expected back, as stated | Stated in |
|---|---|---|---|
| Reboxetine (Edronax®) 4mg tabletsaffected product · inferred from phrasing | Out of stock, as stated | the end of October 2023precision: a month · window end 31 Oct 2023, derived from “the end of October 2023” | notice of 31 Jul 2023 |
| Unlicensed imported stockunlicensed import named by the source · inferred from phrasing | Stated as available | — not stated for this line | notice of 31 Jul 2023 |
Protocol in force
No Serious Shortage Protocol matched to this name is in force on the NHSBSA register. Matching is by name until identifier coding lands.
Named in the source as remaining available
- Unlicensed imported stock — unlicensed import named by the source (inferred from phrasing)
Only names the source itself listed, as it listed them (source post ↗). No substitution, dosing or counselling advice is given here or implied.
Identifiers — Reboxetine
BNF chemical and SNOMED identifiers from NHSBSA Prescription Cost Analysis (Open Government Licence), matched by name (presentation name), confidence 0.90 — grouping under review where marked Release Jul 2026.
BNF SNOMED mapping, NHSBSA Copyright 2026; Prescription Cost Analysis (PCA) Monthly Administrative Data, NHSBSA Copyright 2026. This information is licenced under the terms of the Open Government Licence.
History
One supply notification on record, 31 Jul 2023. We record when a shortage is declared, not when stock returns — the source doesn't publish that. An update sharing a reference counts as one episode.
| Issued | Notice | Kind | Tier | Reference |
|---|---|---|---|---|
| 31 Jul 2023 | Medicine Supply Notification: Reboxetine (Edronax®) 4mg tablets | Supply notification | Tier 2 | MSN/2023/073 |
Also recorded under
Bracketed names seen in this medicine's notice titles: edronax. Grouping is by the head name in each title; brand and generic names may still sit on separate pages until identifier coding refines it — see the A–Z.
Scotland — separate record
NHS Scotland issues its own Medicine Supply Alert Notices. These match this medicine's name; they are shown beside, never added to, the England record.
- MSAN(2023)14 Edronax® (reboxetine) 4mg tablets · issued 07 Aug 2023 · valid until end of October 2023, as stated · matched by name PDF ↗
- MSAN(2019)20 Reboxetine (Edronax®) 4mg tablets · issued 22 Nov 2019 · valid until w/c 16 December 2019, as stated · matched by name PDF ↗